Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More


20% of Cipla FY17 revenues to come from US: Chirag Talati

When asked about the Cipla Indore facility, which has come under the USFDA scanner for manufacturing norms violations, Talati reassures that the facility is not a major contributer to Cipla earnings. Hence this news, he feels should not affect sales.


Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows